Company
Xenon Pharmaceuticals Inc. (XENE)
Standardized SEC financial data for Xenon Pharmaceuticals Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001582313 · NASDAQ · Pharmaceutical Preparations.
Operating margin
-1000.0%
Net margin
-1000.0%
Return on equity
-59.5%
ROIC
-74.0%
Free cash flow
-$279.9M
Debt / equity
0.03×
Current ratio
13.41×
EPS (diluted)
$-4.36
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $32.2M | $18.4M | $9.4M | $0 | $0 | $7.5M |
| R&D expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $45.0M | $175.7M | $57.2M | $148.6M | $142.7M | $199.2M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$48.1M | -$69.5M | -$101.0M | -$151.1M | -$181.4M | -$279.1M |
| Capital expenditures |
Get XENE data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/XENE/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/XENE/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"